[1]
“Cost minimization analysis of generic and innovator formulations of metformin and its combination with other oral antidiabetic drugs”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 8, no. 4, pp. 481–487, Oct. 2019, doi: 10.61096/ijrpp.v8.iss4.2019.481-487.